Joshua Reed | Chief Financial Officer |
Dr. Todd Brady | Chief Executive Officer |
Bruce Greenberg | Incoming Interim CFO |
Justin Kim | Oppenheimer |
Marc Goodman | SVB Leerink |
Yigal Nochomovitz | Citi |
Kelly Shi | Jefferies |
Sung Hong | BTIG |
Matthew Cross | Alliance Global Partners |
Catherine Novack | Jones Trading |
Elaine Kim | Berenberg |
Yale Jen | Laidlaw Capital |
Ladies and gentlemen, thank you for standing by, and welcome to the Aldeyra Therapeutics First Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. I would now like to hand over the conference to company's Chief Financial Officer, Mr. Joshua Reed.